O	O	O	0	11	Differences	Difference	B-NP	NNS	O	0	ROOT	O
O	O	O	12	14	in	in	B-PP	IN	O	1	NMOD	O
T2	B-Entity	B-Entity	15	30	transcriptional	transcriptional	B-NP	JJ	B-DNA	4	NMOD	B-DNA
T2	I-Entity	I-Entity	31	40	enhancers	enhancer	I-NP	NNS	I-DNA	2	PMOD	I-DNA
O	O	O	41	43	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	44	47	HIV	HIV	B-NP	NN	O	12	NMOD	O
O	O	O	47	48	-	-	B-NP	HYPH	O	12	P	O
O	O	O	48	49	1	1	I-NP	CD	O	12	NMOD	O
O	O	O	50	53	and	and	I-NP	CC	O	12	NMOD	O
O	O	O	54	57	HIV	HIV	I-NP	NN	O	12	NMOD	O
O	O	O	57	58	-	-	O	HYPH	O	12	P	O
O	O	O	58	59	2	2	B-NP	CD	O	5	PMOD	O
O	O	O	59	60	.	.	O	.	O	1	P	O

O	O	O	61	69	Response	Response	B-NP	NN	O	0	ROOT	O
O	O	O	70	72	to	to	B-PP	TO	O	1	NMOD	O
O	O	O	73	74	T	T	B-NP	NN	O	6	NMOD	O
O	O	O	75	79	cell	cell	I-NP	NN	O	6	NMOD	O
O	O	O	80	90	activation	activation	I-NP	NN	O	6	NMOD	O
O	O	O	91	98	signals	signal	I-NP	NNS	O	2	PMOD	O
O	O	O	98	99	.	.	O	.	O	1	P	O

O	O	O	101	102	T	T	B-NP	NN	O	3	NMOD	O
O	O	O	103	107	cell	cell	I-NP	NN	O	3	NMOD	O
O	O	O	108	118	activation	activation	I-NP	NN	O	4	SUB	O
O	O	O	119	126	results	result	B-VP	VBZ	O	0	ROOT	O
O	O	O	127	129	in	in	B-PP	IN	O	4	VMOD	O
O	O	O	130	134	high	high	B-NP	JJ	O	7	NMOD	O
O	O	O	135	141	levels	level	I-NP	NNS	O	5	PMOD	O
O	O	O	142	144	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	145	148	HIV	HIV	B-NP	NN	O	10	NMOD	O
O	O	O	149	160	replication	replication	I-NP	NN	O	8	PMOD	O
O	O	O	161	164	and	and	O	CC	O	4	VMOD	O
O	O	O	165	167	is	be	B-VP	VBZ	O	4	VMOD	O
O	O	O	168	175	thought	think	I-VP	VBN	O	12	VC	O
O	O	O	176	178	to	to	I-VP	TO	O	15	VMOD	O
O	O	O	179	181	be	be	I-VP	VB	O	13	VMOD	O
O	O	O	182	185	one	one	B-NP	CD	O	17	NMOD	O
O	O	O	186	195	mechanism	mechanism	I-NP	NN	O	15	PRD	O
O	O	O	196	203	leading	lead	B-VP	VBG	O	17	NMOD	O
O	O	O	204	206	to	to	B-PP	TO	O	18	VMOD	O
O	O	O	207	210	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	211	221	conversion	conversion	I-NP	NN	O	19	PMOD	O
O	O	O	222	226	from	from	B-PP	IN	O	21	NMOD	O
O	O	O	227	233	latent	latent	B-ADJP	JJ	O	22	PMOD	O
O	O	O	234	236	to	to	B-PP	TO	O	22	PMOD	O
O	O	O	237	243	active	active	B-NP	JJ	O	24	PMOD	O
O	O	O	244	249	viral	viral	I-NP	JJ	O	27	NMOD	O
O	O	O	250	259	infection	infection	I-NP	NN	O	22	PMOD	O
O	O	O	259	260	.	.	O	.	O	4	P	O

O	O	O	261	263	In	In	B-PP	IN	O	14	VMOD	O
O	O	O	264	267	HIV	HIV	B-NP	NN	O	4	SUB	O
O	O	O	267	268	-	-	B-NP	HYPH	O	4	P	O
O	O	O	268	269	1	1	I-NP	CD	O	1	PMOD	O
O	O	O	269	270	,	,	O	,	O	14	P	O
O	O	O	271	274	the	the	B-NP	DT	O	7	NMOD	O
T3	B-Entity	B-Entity	275	284	sequences	sequence	I-NP	NNS	O	14	SUB	O
O	O	O	285	289	that	that	B-NP	WDT	O	7	NMOD	O
O	O	O	290	297	respond	respond	B-VP	VBP	O	8	SBAR	O
O	O	O	298	300	to	to	B-PP	TO	O	9	VMOD	O
O	O	O	301	306	these	these	B-NP	DT	O	13	NMOD	O
O	O	O	307	316	signaling	signaling	I-NP	NN	O	13	NMOD	O
O	O	O	317	323	events	event	I-NP	NNS	O	10	PMOD	O
O	O	O	324	327	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	328	333	found	find	I-VP	VBN	O	14	VC	O
O	O	O	334	336	in	in	B-PP	IN	O	15	VMOD	O
O	O	O	337	340	the	the	B-NP	DT	O	20	NMOD	O
T4	B-Entity	B-Entity	341	345	long	long	I-NP	JJ	B-DNA	20	NMOD	B-DNA
T4	I-Entity	I-Entity	346	354	terminal	terminal	I-NP	JJ	I-DNA	20	NMOD	I-DNA
T4	I-Entity	I-Entity	355	361	repeat	repeat	I-NP	NN	I-DNA	16	PMOD	I-DNA
O	O	O	362	363	(	(	O	(	O	23	DEP	O
T5	B-Entity	B-Entity	363	366	LTR	LTR	B-NP	NN	B-DNA	23	DEP	B-DNA
O	O	O	366	367	)	)	O	)	O	20	NMOD	O
O	O	O	368	371	and	and	O	CC	O	14	VMOD	O
O	O	O	372	380	comprise	comprise	B-VP	VBP	O	14	VMOD	O
O	O	O	381	384	the	the	B-NP	DT	O	28	NMOD	O
T6	B-Entity	B-Entity	385	400	transcriptional	transcriptional	I-NP	JJ	B-DNA	28	NMOD	B-DNA
T6	I-Entity	I-Entity	401	409	enhancer	enhancer	I-NP	NN	I-DNA	25	OBJ	I-DNA
O	O	O	409	410	,	,	O	,	O	28	P	O
O	O	O	411	416	which	which	B-NP	WDT	O	28	NMOD	O
O	O	O	417	425	contains	contain	B-VP	VBZ	O	30	SBAR	O
O	O	O	426	429	two	two	B-NP	CD	O	35	NMOD	O
T7	B-Entity	B-Entity	430	439	conserved	conserve	I-NP	VBN	B-DNA	35	NMOD	B-DNA
T7	I-Entity	I-Entity	440	447	binding	bind	I-NP	VBG	I-DNA	35	NMOD	I-DNA
T7	I-Entity	I-Entity	448	453	sites	site	I-NP	NNS	I-DNA	31	OBJ	I-DNA
O	O	O	454	457	for	for	B-PP	IN	O	35	NMOD	O
O	O	O	458	461	the	the	B-NP	DT	O	41	NMOD	O
T8	B-Entity	B-Entity	462	469	nuclear	nuclear	I-NP	JJ	B-protein	41	NMOD	B-protein
T8	I-Entity	I-Entity	470	476	factor	factor	I-NP	NN	I-protein	41	NMOD	I-protein
T8	I-Entity	I-Entity	477	482	kappa	kappa	I-NP	NN	I-protein	41	NMOD	I-protein
T8	I-Entity	I-Entity	483	484	B	B	I-NP	NN	I-protein	36	PMOD	I-protein
O	O	O	485	486	(	(	O	(	O	46	DEP	O
T9	B-Entity	B-Entity	486	488	NF	NF	B-NP	NN	B-protein	45	NMOD	B-protein
T9	I-Entity	I-Entity	489	494	kappa	kappa	I-NP	NN	I-protein	45	NMOD	I-protein
T9	I-Entity	I-Entity	495	496	B	B	I-NP	NN	I-protein	46	DEP	I-protein
O	O	O	496	497	)	)	O	)	O	41	NMOD	O
O	O	O	497	498	.	.	O	.	O	14	P	O

O	O	O	499	502	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	503	516	corresponding	corresponding	I-NP	JJ	O	3	NMOD	O
O	O	O	517	523	region	region	I-NP	NN	O	14	SUB	O
O	O	O	524	526	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	527	530	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	531	537	second	second	I-NP	JJ	O	8	NMOD	O
O	O	O	538	542	AIDS	AIDS	I-NP	NNP	O	8	NMOD	O
O	O	O	543	553	retrovirus	retrovirus	I-NP	NN	O	4	PMOD	O
O	O	O	553	554	,	,	O	,	O	14	P	O
O	O	O	555	558	HIV	HIV	B-NP	NN	O	14	SUB	O
O	O	O	558	559	-	-	O	HYPH	O	10	P	O
O	O	O	559	560	2	2	B-NP	CD	O	10	NMOD	O
O	O	O	560	561	,	,	O	,	O	10	P	O
O	O	O	562	570	contains	contain	B-VP	VBZ	O	0	ROOT	O
O	O	O	571	572	a	a	B-NP	DT	O	16	NMOD	O
O	O	O	573	582	conserved	conserve	I-NP	VBN	O	24	NMOD	O
O	O	O	583	586	and	and	O	CC	O	24	NMOD	O
O	O	O	587	588	a	a	B-NP	DT	O	24	NMOD	O
O	O	O	589	598	divergent	divergent	I-NP	JJ	B-DNA	24	NMOD	B-DNA
T10,T11	B-Entity,B-Entity	B-Entity,B-Entity	599	601	NF	NF	I-NP	NN	I-DNA	24	NMOD	I-DNA
T10,T11	I-Entity,I-Entity	I-Entity,I-Entity	602	607	kappa	kappa	I-NP	NN	I-DNA	24	NMOD	I-DNA
T10,T11	I-Entity,I-Entity	I-Entity,I-Entity	608	609	B	B	I-NP	NN	I-DNA	24	NMOD	I-DNA
T10	I-Entity	I-Entity	610	617	binding	binding	I-NP	NN	I-DNA	24	NMOD	I-DNA
T10	I-Entity	I-Entity	618	622	site	site	I-NP	NN	I-DNA	14	OBJ	I-DNA
O	O	O	622	623	.	.	O	.	O	14	P	O

O	O	O	624	626	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	627	638	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	639	643	that	that	B-SBAR	IN	O	2	VMOD	O
O	O	O	644	647	the	the	B-NP	DT	O	8	NMOD	O
T12	B-Entity	B-Entity	648	651	HIV	HIV	I-NP	NN	B-DNA	8	NMOD	B-DNA
T12	I-Entity	I-Entity	651	652	-	-	B-NP	HYPH	I-DNA	8	NMOD	I-DNA
T12	I-Entity	I-Entity	652	653	1	1	I-NP	CD	I-DNA	8	NMOD	I-DNA
T12	I-Entity	I-Entity	654	657	LTR	LTR	I-NP	NN	I-DNA	9	SUB	I-DNA
O	O	O	658	666	responds	respond	B-VP	VBZ	O	3	SBAR	O
O	O	O	667	673	better	good	B-ADJP	JJR	O	9	VMOD	O
O	O	O	674	678	than	than	B-PP	IN	O	10	AMOD	O
O	O	O	679	682	the	the	B-NP	DT	O	16	NMOD	O
T13	B-Entity	B-Entity	683	686	HIV	HIV	I-NP	NN	B-DNA	16	NMOD	B-DNA
T13	I-Entity	I-Entity	686	687	-	-	O	HYPH	I-DNA	16	NMOD	I-DNA
T13	I-Entity	I-Entity	687	688	2	2	B-NP	CD	I-DNA	16	NMOD	I-DNA
T13	I-Entity	I-Entity	689	692	LTR	LTR	I-NP	NN	I-DNA	11	SBAR	I-DNA
O	O	O	693	695	to	to	B-PP	TO	O	9	VMOD	O
O	O	O	696	697	T	T	B-NP	NN	O	21	NMOD	O
O	O	O	698	702	cell	cell	I-NP	NN	O	21	NMOD	O
O	O	O	703	713	activation	activation	I-NP	NN	O	21	NMOD	O
O	O	O	714	721	signals	signal	I-NP	NNS	O	17	PMOD	O
O	O	O	721	722	.	.	O	.	O	2	P	O

O	O	O	723	728	These	These	B-NP	DT	O	3	NMOD	O
O	O	O	729	740	qualitative	qualitative	I-NP	JJ	O	3	NMOD	O
O	O	O	741	752	differences	difference	I-NP	NNS	O	11	SUB	O
O	O	O	753	755	in	in	B-PP	IN	O	3	NMOD	O
O	O	O	756	759	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	760	768	response	response	I-NP	NN	O	4	PMOD	O
O	O	O	769	771	to	to	B-PP	TO	O	6	NMOD	O
O	O	O	772	773	T	T	B-NP	NN	O	10	NMOD	O
O	O	O	774	778	cell	cell	I-NP	NN	O	10	NMOD	O
O	O	O	779	789	activation	activation	I-NP	NN	O	7	PMOD	O
O	O	O	790	793	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	794	804	reproduced	reproduce	I-VP	VBN	O	11	VC	O
O	O	O	805	808	not	not	B-CONJP	RB	O	15	AMOD	O
O	O	O	809	813	only	only	I-CONJP	RB	O	13	DEP	O
O	O	O	814	818	when	when	B-ADVP	WRB	O	33	DEP	O
O	O	O	819	822	HIV	HIV	B-NP	NN	O	23	NMOD	O
O	O	O	822	823	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	O	823	824	1	1	I-NP	CD	O	23	NMOD	O
O	O	O	825	827	or	or	I-NP	CC	O	23	NMOD	O
O	O	O	828	831	HIV	HIV	I-NP	NN	B-DNA	23	NMOD	B-DNA
O	O	O	831	832	-	-	O	HYPH	I-DNA	23	NMOD	I-DNA
O	O	O	832	833	2	2	B-NP	CD	I-DNA	23	NMOD	I-DNA
T14	B-Entity	B-Entity	834	843	enhancers	enhancer	I-NP	NNS	I-DNA	24	SUB	I-DNA
O	O	O	844	847	are	be	B-VP	VBP	O	15	SBAR	O
O	O	O	848	854	placed	place	I-VP	VBN	O	24	VC	O
O	O	O	855	863	upstream	upstream	B-ADVP	RB	O	25	VMOD	O
O	O	O	864	866	of	of	B-PP	IN	O	26	AMOD	O
O	O	O	867	868	a	a	B-NP	DT	O	30	NMOD	O
T15	B-Entity	B-Entity	869	881	heterologous	heterologous	I-NP	JJ	B-DNA	30	NMOD	B-DNA
T15	I-Entity	I-Entity	882	890	promoter	promoter	I-NP	NN	I-DNA	27	PMOD	I-DNA
O	O	O	891	894	but	but	B-CONJP	CC	O	33	DEP	O
O	O	O	895	899	also	also	I-CONJP	RB	O	31	DEP	O
O	O	O	900	904	when	when	B-ADVP	WRB	O	11	VMOD	O
O	O	O	905	910	these	these	B-NP	DT	O	35	NMOD	O
T16	B-Entity	B-Entity	911	920	enhancers	enhancer	I-NP	NNS	B-DNA	36	SUB	B-DNA
O	O	O	921	924	are	be	B-VP	VBP	O	33	SBAR	O
O	O	O	925	933	switched	switch	I-VP	VBN	O	36	VC	O
O	O	O	934	941	between	between	B-PP	IN	O	37	VMOD	O
O	O	O	942	947	their	their	B-NP	PRP$	O	41	NMOD	O
O	O	O	948	958	respective	respective	I-NP	JJ	O	41	NMOD	O
T17	B-Entity	B-Entity	959	962	LTR	LTR	I-NP	NN	B-DNA	38	PMOD	B-DNA
O	O	O	962	963	.	.	O	.	O	11	P	O

O	O	O	964	966	In	In	B-PP	IN	O	10	VMOD	O
O	O	O	967	982	electrophoretic	electrophoretic	B-NP	JJ	O	5	NMOD	O
O	O	O	983	991	mobility	mobility	I-NP	NN	O	5	NMOD	O
O	O	O	992	997	shift	shift	I-NP	NN	O	5	NMOD	O
O	O	O	998	1004	assays	assay	I-NP	NNS	O	1	PMOD	O
O	O	O	1004	1005	,	,	O	,	O	10	P	O
T18	B-Entity	B-Entity	1006	1008	NF	NF	B-NP	NN	B-protein	9	NMOD	B-protein
T18	I-Entity	I-Entity	1009	1014	kappa	kappa	I-NP	NN	I-protein	9	NMOD	I-protein
T18	I-Entity	I-Entity	1015	1016	B	B	I-NP	NN	I-protein	10	SUB	I-protein
O	O	O	1017	1022	binds	bind	B-VP	VBZ	O	0	ROOT	O
O	O	O	1023	1025	to	to	B-PP	TO	O	10	VMOD	O
O	O	O	1026	1030	both	both	B-NP	DT	O	14	NMOD	O
T19	B-Entity	B-Entity	1031	1040	conserved	conserve	I-NP	VBN	O	14	NMOD	O
T19	I-Entity	I-Entity	1041	1046	sites	site	I-NP	NNS	O	11	PMOD	O
O	O	O	1047	1049	in	in	B-PP	IN	O	14	NMOD	O
O	O	O	1050	1053	the	the	B-NP	DT	O	21	NMOD	O
T20	B-Entity	B-Entity	1054	1057	HIV	HIV	I-NP	NN	B-DNA	21	NMOD	B-DNA
T20	I-Entity	I-Entity	1057	1058	-	-	B-NP	HYPH	I-DNA	21	NMOD	I-DNA
T20	I-Entity	I-Entity	1058	1059	1	1	I-NP	CD	I-DNA	21	NMOD	I-DNA
T20	I-Entity	I-Entity	1060	1075	transcriptional	transcriptional	I-NP	JJ	I-DNA	21	NMOD	I-DNA
T20	I-Entity	I-Entity	1076	1084	enhancer	enhancer	I-NP	NN	I-DNA	15	PMOD	I-DNA
O	O	O	1085	1088	and	and	O	CC	O	11	PMOD	O
O	O	O	1089	1093	only	only	B-ADVP	RB	O	24	PMOD	O
O	O	O	1094	1096	to	to	B-PP	TO	O	11	PMOD	O
O	O	O	1097	1100	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	1101	1107	single	single	I-NP	JJ	O	28	NMOD	O
T21	B-Entity	B-Entity	1108	1117	conserved	conserve	I-NP	VBN	O	28	NMOD	O
T21	I-Entity	I-Entity	1118	1122	site	site	I-NP	NN	O	24	PMOD	O
O	O	O	1123	1125	in	in	B-PP	IN	O	28	NMOD	O
O	O	O	1126	1129	the	the	B-NP	DT	O	35	NMOD	O
T22	B-Entity	B-Entity	1130	1133	HIV	HIV	I-NP	NN	B-DNA	35	NMOD	B-DNA
T22	I-Entity	I-Entity	1133	1134	-	-	B-NP	HYPH	I-DNA	35	NMOD	I-DNA
T22	I-Entity	I-Entity	1134	1135	2	2	I-NP	CD	I-DNA	35	NMOD	I-DNA
T22	I-Entity	I-Entity	1136	1151	transcriptional	transcriptional	I-NP	JJ	I-DNA	35	NMOD	I-DNA
T22	I-Entity	I-Entity	1152	1160	enhancer	enhancer	I-NP	NN	I-DNA	29	PMOD	I-DNA
O	O	O	1160	1161	.	.	O	.	O	10	P	O

O	O	O	1162	1169	Instead	Instead	B-PP	RB	O	11	VMOD	O
O	O	O	1170	1172	of	of	I-PP	IN	O	1	AMOD	O
T23	B-Entity	B-Entity	1173	1175	NF	NF	B-NP	NN	B-protein	5	NMOD	B-protein
T23	I-Entity	I-Entity	1176	1181	kappa	kappa	I-NP	NN	I-protein	5	NMOD	I-protein
T23	I-Entity	I-Entity	1182	1183	B	B	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	O	1183	1184	,	,	O	,	O	11	P	O
O	O	O	1185	1188	the	the	B-NP	DT	O	9	NMOD	O
T1	B-Protein	B-Protein	1189	1198	activator	activator	I-NP	NN	B-protein	9	NMOD	B-protein
T1	I-Protein	I-Protein	1199	1206	protein	protein	I-NP	NN	I-protein	11	SUB	I-protein
T1	I-Protein	I-Protein	1207	1208	3	3	I-NP	CD	I-protein	9	NMOD	I-protein
O	O	O	1209	1214	binds	bind	B-VP	VBZ	O	0	ROOT	O
O	O	O	1215	1217	to	to	B-PP	TO	O	11	VMOD	O
O	O	O	1218	1221	the	the	B-NP	DT	O	15	NMOD	O
T24	B-Entity	B-Entity	1222	1231	divergent	divergent	I-NP	JJ	B-DNA	15	NMOD	B-DNA
T24	I-Entity	I-Entity	1232	1236	site	site	I-NP	NN	I-DNA	12	PMOD	I-DNA
O	O	O	1237	1239	in	in	B-PP	IN	O	15	NMOD	O
O	O	O	1240	1243	HIV	HIV	B-NP	NN	O	19	NMOD	O
O	O	O	1243	1244	-	-	B-NP	HYPH	O	19	P	O
O	O	O	1244	1245	2	2	I-NP	CD	O	16	PMOD	O
O	O	O	1245	1246	.	.	O	.	O	11	P	O

O	O	O	1247	1249	In	In	B-PP	IN	O	11	VMOD	O
O	O	O	1250	1260	conclusion	conclusion	B-NP	NN	O	1	PMOD	O
O	O	O	1260	1261	,	,	O	,	O	11	P	O
O	O	O	1262	1265	HIV	HIV	B-NP	NN	O	10	NMOD	O
O	O	O	1265	1266	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	O	1266	1267	1	1	I-NP	CD	O	10	NMOD	O
O	O	O	1268	1271	and	and	I-NP	CC	O	10	NMOD	O
O	O	O	1272	1275	HIV	HIV	I-NP	NN	O	10	NMOD	O
O	O	O	1275	1276	-	-	O	HYPH	O	10	P	O
O	O	O	1276	1277	2	2	B-NP	CD	O	11	SUB	O
O	O	O	1278	1281	are	be	B-VP	VBP	O	23	VMOD	O
O	O	O	1282	1296	differentially	differentially	I-VP	RB	O	11	VMOD	O
O	O	O	1297	1306	regulated	regulate	I-VP	VBN	O	11	VC	O
O	O	O	1307	1309	by	by	B-PP	IN	O	13	VMOD	O
O	O	O	1310	1311	T	T	B-NP	NN	O	18	NMOD	O
O	O	O	1312	1316	cell	cell	I-NP	NN	O	18	NMOD	O
O	O	O	1317	1327	activation	activation	I-NP	NN	O	18	NMOD	O
O	O	O	1328	1335	signals	signal	I-NP	NNS	O	14	PMOD	O
O	O	O	1335	1336	,	,	O	,	O	23	P	O
O	O	O	1337	1340	and	and	O	CC	O	23	VMOD	O
O	O	O	1341	1345	this	this	B-NP	DT	O	22	NMOD	O
O	O	O	1346	1356	difference	difference	I-NP	NN	O	23	SUB	O
O	O	O	1357	1360	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1361	1368	account	account	I-VP	VB	O	23	VC	O
O	O	O	1369	1372	for	for	B-PP	IN	O	24	VMOD	O
O	O	O	1373	1376	the	the	B-NP	DT	O	28	NMOD	O
O	O	O	1377	1383	longer	long	I-NP	JJR	O	28	NMOD	O
O	O	O	1384	1390	period	period	I-NP	NN	O	25	PMOD	O
O	O	O	1391	1393	of	of	B-PP	IN	O	28	NMOD	O
O	O	O	1394	1399	viral	viral	B-NP	JJ	O	31	NMOD	O
O	O	O	1400	1407	latency	latency	I-NP	NN	O	29	PMOD	O
O	O	O	1408	1416	observed	observe	B-VP	VBN	O	28	NMOD	O
O	O	O	1417	1421	with	with	B-PP	IN	O	32	VMOD	O
O	O	O	1422	1425	HIV	HIV	B-NP	NN	O	36	NMOD	O
O	O	O	1425	1426	-	-	O	HYPH	O	36	P	O
O	O	O	1426	1427	2	2	B-NP	CD	O	33	PMOD	O
O	O	O	1428	1432	than	than	B-PP	IN	O	32	VMOD	O
O	O	O	1433	1437	with	with	B-PP	IN	O	37	PMOD	O
O	O	O	1438	1441	HIV	HIV	B-NP	NN	O	42	NMOD	O
O	O	O	1441	1442	-	-	B-NP	HYPH	O	42	NMOD	O
O	O	O	1442	1443	1	1	I-NP	CD	O	42	NMOD	O
O	O	O	1444	1453	infection	infection	I-NP	NN	O	38	PMOD	O
O	O	O	1453	1454	.	.	O	.	O	23	P	O
